San Francisco, CA, United States of America

Atsushi Edward Osawa

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsushi Edward Osawa. Retrieved from https://idiyas.com/inventor/atsushi-edward-osawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 88.9

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 53(Granted Patents)

Company Filing History:

Baxter International Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12208176 - Process for making dry and stable hemostatic compositions (2025-01-28),

2. 11071804 - Hemostatic sponge (2021-07-27),

3. 10994045 - Process for making dry and stable hemostatic compositions (2021-05-04),

4. 10245348 - Process for making dry and stable hemostatic compositions (2019-04-02),

5. 9872934 - Hemostatic sponge (2018-01-23),

6. 9517287 - Hemostatic sponge (2016-12-13),

7. 9408945 - Process for making dry and stable hemostatic compositions (2016-08-09),

8. 9084728 - Process for making dry and stable hemostatic compositions (2015-07-21),

9. 8771258 - Hemostatic sponge (2014-07-08),

Title: Atsushi Edward Osawa: Innovator in Hemostatic Compositions

Introduction

Atsushi Edward Osawa is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical technology, particularly in the development of hemostatic compositions. With a total of 9 patents to his name, Osawa's work has had a profound impact on medical practices.

Latest Patents

Osawa's latest patents include a process for making dry and stable hemostatic compositions. This innovative process is designed to create a hemostatic sponge that comprises oxidized cellulose and a bioadhesive material. The bioadhesive is stably associated with the sponge and is present in an organized pattern, enhancing its effectiveness in medical applications.

Career Highlights

Throughout his career, Atsushi Edward Osawa has worked with prominent companies such as Baxter International Inc. and Baxter Healthcare. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in medical technology.

Collaborations

Osawa has collaborated with several professionals in his field, including Andreas Goessl and Cary J. Reich. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Atsushi Edward Osawa's contributions to the field of hemostatic compositions exemplify his dedication to medical innovation. His patents and collaborations reflect a commitment to improving healthcare solutions.

Profile summary based on public USPTO records.